13F

Stock

Tarsus Pharmaceuticals, Inc.

TARS · held by 1 managers

Reported value

$957K

Holders

1

+0 new · −0 exited

Holders’ est. mark

$28.9K

Price effect on 1 books still in the name

Largest holder

$957K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC47.3K$957K$28.9KAdded$750.2K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.